QUEST DIAGNOSTICS INC

Key metrics

Financial performance

Over the last 9 fiscal years QUEST DIAGNOSTICS INC's revenue grew from $7.21B to $11.04B, a compound annual growth rate of 4.8%. Net profit margin expanded from 8.9% to 9.0% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (2,372 filings)

Recent press releases

• Quest Diagnostics Declares Quarterly Cash Dividend2026-05-19

  **About Quest Diagnostics** Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 57,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com.

• Quest Diagnostics Prices $500 Million of Senior Notes2026-04-27

  This press release shall not constitute an offer to sell or a solicitation of an offer to purchase any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This offering may be made only by means of a prospectus supplement and accompanying base prospectus, copies of which or information concerning this offering may be obtained by calling Goldman Sachs & Co. LLC, toll free at 1 (866) 471-2526, J.P. Morgan Securities LLC, collect at 1-212-834-4533 or Mizuho Securities USA LLC, toll free at 1-866-271-7403.

• Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 20262026-04-21

  First quarter revenues of $2.90 billion, up 9.2% from 2025, with 9.0% organic revenue growth

• City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers2026-04-16

  **_Fourteen City of Hope sites across the U.S. participating in research using the Haystack MRD ctDNA Test in patients with breast, colorectal, ovarian, and prostate cancer_**

• Quest Diagnostics to Release First Quarter Financial Results on April 21, 20262026-03-19

  The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call.

Similar companies

The largest companies sharing QUEST DIAGNOSTICS INC's SEC industry classification (services-medical laboratories).